If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.50
Bid: 51.00
Ask: 52.00
Change: -0.50 (-0.96%)
Spread: 1.00 (1.961%)
Open: 52.00
High: 52.00
Low: 51.50
Prev. Close: 52.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

16 Mar 2010 12:25

RNS Number : 6599I
Scientific Digital Imaging Plc
16 March 2010
 



16 March 2010

SCIENTIFIC DIGITAL IMAGING PLC

("SDI", "the Company" or "the Group")

Directorate Changes

SDI is pleased to announce the appointment of Dr Ann Simon and Ken Ford to its Board as non-executive Directors with immediate effect.

Ann Simon has worked in finance, particularly in the healthcare and technology sectors, since 1985. She is presently Chief Financial Officer of Sphere Medical Holding plc. Over the last decade she has been CFO of Genosis plc, Mirada Solutions, NextGen Sciences, e-San and Bioglan Pharma. She has managed IPOs (London full list and AIM), corporate acquisitions and trade sales and fund raisings in the public and private markets. Prior to that she undertook corporate finance advisory work at Cazenove & Co. over a period of more than ten years for clients ranging from start-ups to FTSE100 companies. She was on the FSA's Financial Information Theme Team from 2002 to 2003. Dr Simon will serve as chairman of the Audit Committee.

Ken Ford was previously Chief Executive of Teather & Greenwood the investment bank, becoming Deputy Chairman and Chairman of Corporate Finance in 2004, and brings over 36 years City experience to the Company, including a strong understanding of shareholder value, strategic planning and corporate transactions. Mr Ford was Chairman of the UK Society of Investment Analysts between 1985 - 1987, is a former Chairman of the Quoted Company's Alliance (QCA) and a former member of the EU Advisory Committee to the Corporation of London. Ken's previous directorships include Aberdeen Asset Management, Morgan Grenfell and Wedd Durlacher. Ken is currently a director at AIM-listed companies BrainJuicer Group and Highams Systems Services Group.

As previously announced, Mr. Alf Vaisey will retire from the Board at the end of March.

Harry Tee CBE, Chairman of SDI, commented:

"I am delighted to be able to announce the appointment of two such capable individuals to the Board. I'm sure they will make a great contribution to the furtherance of the Group's strategy."

Other disclosable information

Ann Juliet Bateman Simon, aged 56, is or has been a director of the following companies during the last five years:

Current directorships

Past directorships

Sphere Medical Holding plc

Endace Europe Limited

Sphere Medical Limited

e-San Limited

The Mirada Shareholder Representative Company Limited

e-San Holdings Limited

Genosis PLC

Genosis (UK) Limited

Dr Simon resigned as a director of Bioglan Laboratories Ltd on 14 February 2001 and as a director of Bioglan Pharma Plc and Bioglan (Holdings) Ltd on 1 November 2001. Receivers were appointed in respect of Bioglan Laboratories Ltd, administrators were appointed in respect of Bioglan Pharma Plc and administrators were appointed in respect of Bioglan (Holdings) Ltd all on 21 February 2002. On 27 February 2003, the joint liquidators stated in a letter to creditors of Bioglan Pharma Plc and Bioglan (Holdings) Ltd that the indebtedness due to the secured creditors of those companies was in excess of £113 million and that they anticipated a shortfall of £75 million to those creditors. The joint liquidators also stated at that time that due to the shortfall to the secured creditors there would not be sufficient funds for a dividend to unsecured creditors and consequently that there would be no return to shareholders.

There are no further disclosures to be made regarding this appointment under Schedule 2 paragraph (g) of the AIM rules.

Eric Kenelm Ford, (Ken Ford), aged 60, is or has been a director of the following companies during the last five years:

Current directorships

Past directorships

Brainjuicer Limited

Atlantic Coal plc

BrainJuicer Group plc

Camomile Wood Nominees Limited

Flying Kiwi Inns Limited

Escalon Investments Limited

Highams Systems Services Group plc

Flying Kiwi (Holdings) limited

Lewis Communications Limited

Landsbanki Securities (UK) Holdings plc

Lewis Communications (Holdings) Limited

Teather and Greenwood Nominees Limited

Mintonview Limited

Teathers limited

Principal Residential Properties Limited

Teawood Nominees Limited

7Safe Limited

 

By Board Notice 431 dated 16 July 1997 the Securities and Futures Authority ("SFA") gave notice that disciplinary proceedings brought against Teather & Greenwood Limited Partnership (of which Mr Ford was a partner) and Mr Ford relating to breaches of the Securities and Investment Board Principles 2 and 9 had been concluded by Settlement with the following outcome:

a) Teather & Greenwood Limited Partnership was reprimanded, fined £50,000 and agreed to pay a contribution of £10,000 towards SFA's costs; and

b) Mr Ford was reprimanded, fined £8,000 and agreed to pay a contribution of £2,000 towards SFA's costs.

 SFA took into account that Teather & Greenwood Limited Partnership had previously conducted a full internal review of its compliance procedures and had implemented a remedial action plan. SFA also took into account that neither Teather & Greenwood Partnership nor Mr Ford has previously been the subject of disciplinary action, both cooperated with SFA and no clients had been disadvantaged. Mr Ford was also reprimanded by the Securities Institute as a result.

There are no further disclosures to be made regarding this appointment under Schedule 2 paragraph (g) of the AIM rules.

--END--

FOR FURTHER INFORMATION

Scientific Digital Imaging plc 01223 727144

Harry Tee CBE, Chairman

Phil Atkin, CEO

www.scientificdigitalimaging.com 

Grant Thornton Corporate Finance (Nominated Advisor) 020 7383 5100

Philip Secrett

Colin Aaronson

Astaire Securities plc 020 7448 4400

Katie Shelton

 

Bishopsgate Communications 020 7562 3350

Will Tindall

Gemma O'Hara

sdi@bishopsgatecommunications.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUBGWUPUGPQ
Date   Source Headline
3rd Apr 20242:15 pmRNSExercise of Share Options and Total Voting Rights
18th Mar 202412:49 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20243:15 pmRNSHolding(s) in Company
26th Feb 20247:00 amRNSLong Term Incentive Plan Awards
23rd Feb 202411:00 amRNSHolding(s) in Company
21st Feb 20246:00 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSHolding(s) in Company
13th Feb 202411:14 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSDirectorate Change – Appointment of New CEO
8th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 20232:30 pmRNSHolding(s) in Company
7th Dec 20231:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSInterim Results
4th Dec 20237:00 amRNSNotice of Results and Investor Presentation
7th Nov 20234:10 pmRNSDirector/PDMR Shareholding
7th Nov 20233:50 pmRNSDirector/PDMR Shareholding and TVR - Replacement
7th Nov 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
6th Nov 20237:00 amRNSAcquisition of Peak Sensors
31st Oct 20234:20 pmRNSHolding(s) in Company
26th Oct 20235:45 pmRNSHolding(s) in Company
29th Sep 202311:30 amRNSResult of AGM
29th Sep 20237:00 amRNSAGM Trading Update
24th Aug 20237:00 amRNSBoard Appointment
8th Aug 20237:00 amRNSFinal Results
2nd Aug 20237:00 amRNSNotice of Results and Investor Presentation
26th May 20231:40 pmRNSHolding(s) in Company
16th May 20232:55 pmRNSHolding(s) in Company
11th May 202311:50 amRNSDirector Dealing
11th May 20237:00 amRNSTrading Update
19th Apr 20231:00 pmRNSDirector/PDMR Shareholding and TVR
12th Apr 20235:15 pmRNSDirector/PDMR Shareholding
31st Mar 20233:45 pmRNSDirector Dealing
15th Mar 202312:00 pmRNSHolding(s) in Company
15th Feb 20235:30 pmRNSHolding(s) in Company
13th Feb 20233:55 pmRNSHolding(s) in Company
3rd Feb 20232:00 pmRNSExercise of Options and Total Voting Rights
1st Feb 202310:15 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBoard Appointment
5th Jan 202310:00 amRNSExercise of Options and Total Voting Rights
14th Dec 20224:00 pmRNSExercise of Options and Total Voting Rights
7th Dec 20227:00 amRNSInterim Results
7th Nov 20227:00 amRNSInvestor Presentation
3rd Nov 20227:00 amRNSNotice of Results
27th Oct 20223:55 pmRNSDirector Dealings, Exercise of Options and TVR
26th Oct 20227:00 amRNSLong Term Incentive Plan Awards
24th Oct 20227:00 amRNSAcquisition of Fraser Anti-Static Techniques Ltd
21st Sep 20224:15 pmRNSResult of AGM and Board Appointment
21st Sep 20227:00 amRNSAGM Trading Update
24th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.